223 related articles for article (PubMed ID: 22036162)
1. Response to "Stereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo." (Int J Radiat Oncol Biol Phys 2011;79:1599-1600) and "Influence of tumor hypoxia on stereotactic ablative radiotherapy (SABR): response to Drs. Mayer and Timmerman." (Int J Radiation Oncol Biol Phys 2011;78:1600).
Song CW; Levitt SH; Park H
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1193; author reply 1193-4. PubMed ID: 22036162
[No Abstract] [Full Text] [Related]
2. Stereotactic ablative radiotherapy in the framework of classical radiobiology: response to Drs. Brown, Diehn, and Loo.
Meyer J; Timmerman R
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1599-600; author reply 1600. PubMed ID: 21414517
[No Abstract] [Full Text] [Related]
3. Modeling prostate cancer: in regards to Nahum et al. (Int J Radiat Oncol Biol Phys 2003;57:391-401).
Wang JZ; Mayr NA; Li XA; Stewart RD
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):309-10; author reply 310-1. PubMed ID: 15629636
[No Abstract] [Full Text] [Related]
4. In regard to Arvold et al. (Int J Radiat Oncol Biol Phys 2005;62:207-212).
Moeller BJ; Dewhirst MW
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):970-1; author reply 971. PubMed ID: 16199328
[No Abstract] [Full Text] [Related]
5. In regard to Vordermark et al. (Int J Radiat Oncol Biol Phys 2004;58:1242-1250).
Koch CJ
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):1003-4; author reply 1004-5. PubMed ID: 15465220
[No Abstract] [Full Text] [Related]
6. MRI for cervical cancer not only correlates with tumor hypoxia, but also predicts ultimate outcome: in regard to Lim et al. (Int J Radiat Oncol Biol Phys 2008;70:126-133).
Wang JZ; Mayr NA; Zhang D; Yuh WT
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1602-3; author reply 1603. PubMed ID: 18640508
[No Abstract] [Full Text] [Related]
7. Toward a unified survival curve: in regard to Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852) and Krueger et al. (Int J Radiat Oncol Biol Phys 2007;69:1262-1271).
Kavanagh BD; Newman F
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):958-9. PubMed ID: 18514788
[No Abstract] [Full Text] [Related]
8. When Is a "BED" not a "BED"?-When it is an EQD2: In regard to Buyyounouski et al. (Int J Radiat Oncol Biol Phys 2010;76:1297-1304).
Fowler JF; Dale RG
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):640-1. PubMed ID: 20832672
[No Abstract] [Full Text] [Related]
9. Toward a unified survival curve: in regard to Kavanagh and Newman (Int J Radiat Oncol Biol Phys 2008;71:958-959) and Park et al. (IntJ Radiat Oncol Biol Phys 2008;70:847-852).
McKenna F; Ahmad S
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):640; author reply 640-1. PubMed ID: 19147035
[No Abstract] [Full Text] [Related]
10. Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol: in regard to Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860).
Vordermark D; Kölbl O
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):296-7; author reply 297. PubMed ID: 15850943
[No Abstract] [Full Text] [Related]
11. Adjuvant whole brain radiotherapy: strong emotions decide but rationale studies are needed: in regard to Brown et al. (Int J Radiat Oncol Biol Phys 2008;70:1305-1309). In reply to Drs. Larson and Sahgal.
Brown PD; Kee AY; Eshleman JS; Fiveash JB
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):316-7. PubMed ID: 19695444
[No Abstract] [Full Text] [Related]
12. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy: in regard to Parks et al. (Int J Radiat Oncol Biol Phys 2008;72:1620-1621).
Tomé WA
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286. PubMed ID: 19251106
[No Abstract] [Full Text] [Related]
13. BED calculations for fractions of very high dose: in regard to Park et al. (Int J Radiat Oncol Biol Phys 2007;69:S623-S624).
Astrahan M
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):963; author reply 963-4. PubMed ID: 18514798
[No Abstract] [Full Text] [Related]
14. Radiotherapy in pleural malignant mesothelioma: why not! In regard to Scorsetti et al. (Int J Radiat Oncol Biol Phys 2010;77:942-949); Krayenbuehl et al. (Int J Radiat Oncol Biol Phys 2010;78:628-634).
Russi EG; Numico G; Ricardi U
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1279; author reply 1279-80. PubMed ID: 21353165
[No Abstract] [Full Text] [Related]
15. Stereotactic radiotherapy of primary lung cancer and other targets: results of consultant meeting of the International Atomic Energy Agency (Int J Radiat Oncol Biol Phys 2011;79:660-669).
Atalar B; Caglar H; Ozyar E
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):521; author reply 521. PubMed ID: 22244280
[No Abstract] [Full Text] [Related]
16. Computed 88% TCP dose for SBRT of NSCLC from tumour hypoxia modelling.
Ruggieri R; Stavreva N; Naccarato S; Stavrev P
Phys Med Biol; 2013 Jul; 58(13):4611-20. PubMed ID: 23771131
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgery for vestibular schwannomas: in regard to Kapoor et al. (Int J Radiat Oncol Biol Phys 2011;81:647-653).
Roos DE
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1324. PubMed ID: 22385724
[No Abstract] [Full Text] [Related]
18. Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer: in regards to Register et al. Int J Radiat Oncol Biol Phys 2011;80:1015-1022.
Bongers EM; Dahele MR; Slotman BJ; Senan S; Bot JC
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):492; author reply 492. PubMed ID: 22182718
[No Abstract] [Full Text] [Related]
19. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer: in regard to Roh et Al (Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1348-55.
Yazici G; Cengiz M; Akyol F
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1278; author reply 1278. PubMed ID: 20206031
[No Abstract] [Full Text] [Related]
20. Analysis of patients with oligometastases undergoing two or more curative-intent stereotactic radiotherapy courses: in regard to Milano et al. (Int J Radiat Oncol Biol Phys 2009;73:832-837).
Christodouleas JP; Marks LB
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1628; author reply 1628-9. PubMed ID: 19616752
[No Abstract] [Full Text] [Related]
[Next] [New Search]
